U.S. officials expect supply of COVID-19 vaccines to exceed domestic demand by mid-May if not faster, and are working on what should be done with money that is to come when vaccine shortage comes to a glut, The New York Times reported Saturday.
U.S. President Joe Biden has promised enough doses by the end of May to vaccinate U.S. adults, but between then and the end of July, the government has locked promises from manufacturers for vaccines enough to cover another 100 million people – “tens of millions more than the total population of the country,” the newspaper said.
“Whether these orders are maintained, changed or redirected is a matter of great impact, not only on the country’s efforts to contain the virus but also for how quickly the end of pandemic.Of the vaccination doses given worldwide, around three are headquartered to just 10 countries.At least 30 countries have not introduced one person , “the report said.
At the same time, global shortages threaten to intensify as countries and regions decimate vaccine exports. With diseases soaring upwards, India, which had been a major vaccine circulator, is now withholding almost all of its 2.4 million doses. they were made every day by a private company there. That action follows the European Union’s decision this week to pass emergency legislation that would ban vaccine exports for the next six weeks, according to the report.
Biden administration officials have pointed out that the rest of the U.S. is likely to hold on to unfulfilled use and uncertainty is rising – children and teens remain unvaccinated, and no one is sure whether or not when immunity could wear off, which could require scores of millions. of elevation pictures.
Vaccine manufacturers and some top federal officials said decisions about what should be done with additional orders must be made within weeks, or the uncertainty could delay production lines.
The manufacturing process can take up to 10 weeks, and changes for a foreign market take time. The regulatory rules governing vaccine behavior pose another hurdle, as is the limited storage life of the vaccine-producing drug products, according to the report.
Shops in the bottle plants in Michigan and Indiana are identified for home use. If their destination is unclear, the product line has to stop or overseas-directed labels may have to be renamed.
As soon as the doses are sent out to states, federal regulations prohibit their return even if they are not needed at home. And filters can never sit in a store – although the vaccine itself can last up to a year in a frozen state, once bottled it must be used within four to six months, the newspaper reported.
“All of these variables threaten to complicate what has been relatively smooth for Biden’s administration,” he said.
